AscendEX is excited to announce the listing of DOSE under the trading pair: $DOSE/USDT. Trading began on May 4th. DOSE helps bring fitness and gaming together within the OliveX ecosystem.
The OliveX team is building a fitness metaverse that enables real-world fitness to merge with the digital universe, blending health and fitness with gaming. With DOSE, users can work out and receive token rewards to unlock in-game items, purchase NFTs, and participate in special events and game modes. The goal is to motivate users to stay active and healthy while also having fun in the digital world.
The guiding principles behind DOSE are Fun Games, Fitness First, and Immersive Experience. Fun Games is the fundamental driver of their games, and the mission-based story is designed to engage and motivate players through exciting gameplay, incentivized by in-game rewards.
Fitness First is at the core of the OliveX games, with players running, riding, or working out through a series of fun and adventurous missions. The Immersive Experience relies on a solid fitness app with metric tracking that allows players to set and pursue their own goals.
DOSE is an ERC-20 Token on the Ethereum, Binance Smart Chain (BSC), and Polygon networks. Its name is an acronym for the chemicals released when you exercise: Dopamine, Oxytocin, Serotonin, Endorphin. These chemicals are known for their ability to make you feel good and can help motivate you to continue exercising. With DOSE, users can experience these same feelings of reward and motivation in the gaming world.
About AscendEX
Launched in 2018, AscendEX is a global cryptocurrency exchange, servicing retail and institutional clients globally, through its comprehensive product suite including spot, margin, and futures trading, wallet services, and staking support for over 200 blockchain projects such as Bitcoin, Ether, Solana, Cardana, and more.
With the new listing of DOSE token on AscendEX, it opens a new entry point for investors and gaming fans to get paid to play and be active!
For more information and updates on AscendEX, please visit:
For more information and updates about DOSE, please visit:
Disclaimer
This article contains a press release provided by an external source and may not necessarily reflect the views or opinions of BeInCrypto. In compliance with the Trust Project guidelines, BeInCrypto remains committed to transparent and unbiased reporting. Readers are advised to verify information independently and consult with a professional before making decisions based on this press release content. Please note that our Terms and Conditions, Privacy Policy, and Disclaimers have been updated.
